Nkarta, Inc. (NKTX) Executive Compensation
Nkarta, Inc. (NKTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NKTX
CIK: 1787400
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerAbdul Kazi
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001787400-26-000017 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342402 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-18 | 4 | 0001193125-26-277507 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-10 | 8-K | 0001193125-26-267830 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 Filing | 0001231919-26-000621 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267632 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267601 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267538 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267524 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267521 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267519 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267517 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-19 | — | SCHEDULE 13D/A Filing | 0001072613-26-000486 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001787400-26-000013 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001787400-26-000012 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001140361-26-016408 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001140361-26-016407 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-23 | 2026-06-10 | DEF 14A | 0001140361-26-016403 | View SEC Doc Filr Page |
| EFFECT | 2026-04-03 | — | EFFECT Filing | 9999999995-26-001085 | View SEC Doc Filr Page |
| 424B5 | 2026-04-03 | — | 424B5 | 0001140361-26-013179 | View SEC Doc Filr Page |
| CORRESP | 2026-04-01 | — | CORRESP Filing | 0001140361-26-012780 | View SEC Doc Filr Page |
| UPLOAD | 2026-03-31 | — | UPLOAD Filing | 0000000000-26-003267 | View SEC Doc Filr Page |
| 8-K | 2026-03-26 | 2026-03-25 | 8-K | 0001787400-26-000008 | View SEC Doc Filr Page |
| S-3 | 2026-03-25 | — | S-3 | 0001140361-26-011152 | View SEC Doc Filr Page |
| 10-K | 2026-03-25 | 2025-12-31 | 10-K | 0001787400-26-000006 | View SEC Doc Filr Page |